Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perioperative Tegafur Gimeracil Oteracil Potassium Capsule Plus Oxaliplatin Versus Capecitabine Plus Oxaliplatin in Patients With Localized Advanced Gastric Cancer

NCT01516944 is registered in ClinicalTrials.gov with Hebei Medical University as lead sponsor.

NCT NCT01516944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01516944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perioperative Tegafur Gimeracil Oteracil Potassium Capsule Plus Oxaliplatin Versus Capecitabine Plus Oxaliplatin in Patients With Localized Advanced Gastric Cancer
Lead sponsor
Hebei Medical University
Phase
Phase 2/3
Overall status
Completed
Start date
February 29, 2012
Completion date
December 31, 2018
Enrollment
749 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer